Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Utility of pre-procedural CT and abdominal radiography before percutaneous radiologic gastrostomy placement.

Gutjahr CJ, Iverson EP, Walker ST, Johnson JD, Shukla UC, Terrell W.

Abdom Radiol (NY). 2019 Dec 3. doi: 10.1007/s00261-019-02352-1. [Epub ahead of print]

PMID:
31797024
2.

A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection.

Zoulim F, Moreno C, Lee SS, Buggisch P, Horban A, Lawitz E, Corbett C, Lenz O, Fevery B, Verbinnen T, Shukla U, Jessner W.

Virol J. 2018 Jan 30;15(1):26. doi: 10.1186/s12985-018-0936-4.

3.

A Comparative Study of Analgesic Effect of Intrathecal Nalbuphine and Fentanyl as Adjuvant in Lower Limb Orthopaedic Surgery.

Naaz S, Shukla U, Srivastava S, Ozair E, Asghar A.

J Clin Diagn Res. 2017 Jul;11(7):UC25-UC28. doi: 10.7860/JCDR/2017/24385.10224. Epub 2017 Jul 1.

4.

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study.

Gane EJ, DeJesus E, Janczewska E, George J, Diago M, Da Silva MH, Reesink H, Nikitin I, Hinrichsen H, Bourgeois S, Ferenci P, Shukla U, Kalmeijer R, Lenz O, Fevery B, Corbett C, Beumont M, Jessner W.

BMC Infect Dis. 2017 Jun 2;17(1):389. doi: 10.1186/s12879-017-2444-3.

5.

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.

Forns X, Berenguer M, Herzer K, Sterneck M, Donato MF, Andreone P, Fagiuoli S, Cieciura T, Durlik M, Calleja JL, Mariño Z, Shukla U, Verbinnen T, Lenz O, Ouwerkerk-Mahadevan S, Peeters M, Janssen K, Kalmeijer R, Jessner W.

Transpl Infect Dis. 2017 Jun;19(3). doi: 10.1111/tid.12696. Epub 2017 May 4.

PMID:
28295849
6.

Cronkhite Canada syndrome complicated by pulmonary embolism-A case report.

Nemade NL, Shukla UB, Wagholikar GD.

Int J Surg Case Rep. 2017;30:17-22. doi: 10.1016/j.ijscr.2016.11.020. Epub 2016 Nov 17.

7.

Prevalence of celiac disease in Indian children with type 1 diabetes.

Srivastava A, Chaturvedi S, Dabadghao P, Mathias A, Shukla U, Singh U, Yachha SK.

Indian J Gastroenterol. 2016 Sep;35(5):372-378. Epub 2016 Sep 24.

PMID:
27663711
8.

Dexmedetomidine versus midazolam as adjuvants to intrathecal bupivacaine: A clinical comparison.

Shukla U, Prabhakar T, Malhotra K, Srivastava D.

J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):214-9. doi: 10.4103/0970-9185.182105.

9.

Hypertriglyceridemia Thalassemia Syndrome: Common Disease, Uncommon Association.

Das L, Samprathi M, Shukla U, Bandyopadhyay D, Das RR.

Indian J Pediatr. 2016 Jul;83(7):720-2. doi: 10.1007/s12098-016-2062-x. Epub 2016 Mar 3.

PMID:
26935201
10.

Correction: Crocodilian Nest in a Late Cretaceous Sauropod Hatchery from the Type Lameta Ghat Locality, Jabalpur, India.

Srivastava R, Patnaik R, Shukla UK, Sahni A.

PLoS One. 2016 Jan 5;11(1):e0146736. doi: 10.1371/journal.pone.0146736. eCollection 2016. No abstract available.

11.

Crocodilian Nest in a Late Cretaceous Sauropod Hatchery from the Type Lameta Ghat Locality, Jabalpur, India.

Srivastava R, Patnaik R, Shukla UK, Sahni A.

PLoS One. 2015 Dec 7;10(12):e0144369. doi: 10.1371/journal.pone.0144369. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0146736.

12.

Intraperitoneal bupivacaine alone or with dexmedetomidine or tramadol for post-operative analgesia following laparoscopic cholecystectomy: A comparative evaluation.

Shukla U, Prabhakar T, Malhotra K, Srivastava D, Malhotra K.

Indian J Anaesth. 2015 Apr;59(4):234-9. doi: 10.4103/0019-5049.155001.

13.

A simple experimental method to determine magnetic field topology in toroidal plasma devices.

Thatipamula SG, Shukla UK, Ganesh R, Saxena YC, Raju D.

Rev Sci Instrum. 2015 Mar;86(3):033504. doi: 10.1063/1.4914388.

PMID:
25832226
14.

Reduced hornbill abundance associated with low seed arrival and altered recruitment in a hunted and logged tropical forest.

Naniwadekar R, Shukla U, Isvaran K, Datta A.

PLoS One. 2015 Mar 17;10(3):e0120062. doi: 10.1371/journal.pone.0120062. eCollection 2015.

15.

Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4.

Moreno C, Hezode C, Marcellin P, Bourgeois S, Francque S, Samuel D, Zoulim F, Grange JD, Shukla U, Lenz O, Ouwerkerk-Mahadevan S, Fevery B, Peeters M, Beumont M, Jessner W.

J Hepatol. 2015 May;62(5):1047-55. doi: 10.1016/j.jhep.2014.12.031. Epub 2015 Jan 14.

PMID:
25596313
16.

Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs.

Dombkowski AA, Batista CE, Cukovic D, Carruthers NJ, Ranganathan R, Shukla U, Stemmer PM, Chugani HT, Chugani DC.

Cereb Cortex. 2016 Mar;26(3):1059-71. doi: 10.1093/cercor/bhu276. Epub 2014 Dec 1.

17.

Hand hygiene compliance among healthcare workers in an accredited tertiary care hospital.

Chavali S, Menon V, Shukla U.

Indian J Crit Care Med. 2014 Oct;18(10):689-93. doi: 10.4103/0972-5229.142179.

18.

Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 study.

Dieterich D, Rockstroh JK, Orkin C, Gutiérrez F, Klein MB, Reynes J, Shukla U, Jenkins A, Lenz O, Ouwerkerk-Mahadevan S, Peeters M, De La Rosa G, Tambuyzer L, Jessner W.

Clin Infect Dis. 2014 Dec 1;59(11):1579-87. doi: 10.1093/cid/ciu675. Epub 2014 Sep 5.

PMID:
25192745
19.

Traumatic subclavian arterial thrombosis presenting with cerebral infarct--a case report.

Chavali S, Shukla U, Chauta S.

Heart Lung Circ. 2014 Oct;23(10):e202-6. doi: 10.1016/j.hlc.2014.04.254. Epub 2014 Jun 16.

PMID:
25012053
20.

Relevance of ankle reflex as a screening test for diabetic peripheral neuropathy.

Malik MM, Jindal S, Bansal S, Saxena V, Shukla US.

Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S340-1. doi: 10.4103/2230-8210.119641.

21.

Relationship of serum thyroid stimulating hormone with body mass index in healthy adults.

Solanki A, Bansal S, Jindal S, Saxena V, Shukla US.

Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S167-9. doi: 10.4103/2230-8210.119560.

22.

Methods to evaluate and improve the injection site tolerability of intravenous formulations prior to first-in-human testing.

Eichenbaum G, Zhou J, De Smedt A, De Jonghe S, Looszova A, Arien T, Van Goethem F, Vervoort I, Shukla U, Lammens L.

J Pharmacol Toxicol Methods. 2013 Nov-Dec;68(3):394-406. doi: 10.1016/j.vascn.2013.08.002. Epub 2013 Aug 8.

PMID:
23933112
24.

The Tei index and asymptomatic myocarditis in children with severe dengue.

Yadav DK, Choudhary S, Gupta PK, Beniwal MK, Agarwal S, Shukla U, Dubey NK, Sankar J, Kumar P.

Pediatr Cardiol. 2013 Aug;34(6):1307-13. doi: 10.1007/s00246-013-0639-y. Epub 2013 Feb 9.

PMID:
23397334
25.

Sperm donor recruitment, attitudes and provider practices--5 years after the removal of donor anonymity.

Shukla U, Deval B, Jansa Perez M, Hamoda H, Savvas M, Narvekar N.

Hum Reprod. 2013 Mar;28(3):676-82. doi: 10.1093/humrep/des450. Epub 2013 Jan 12.

PMID:
23315068
26.

Effect of magnesium sulfate with propofol induction of anesthesia on succinylcholine-induced fasciculations and myalgia.

Kumar M, Talwar N, Goyal R, Shukla U, Sethi A.

J Anaesthesiol Clin Pharmacol. 2012 Jan;28(1):81-5. doi: 10.4103/0970-9185.92451.

27.

Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2.

Eichenbaum G, Pugsley MK, Gallacher DJ, Towart R, McIntyre G, Shukla U, Davenport JM, Lu HR, Rohrbacher J, Hillsamer V.

Br J Pharmacol. 2012 Jul;166(5):1694-707. doi: 10.1111/j.1476-5381.2012.01874.x.

28.

Bioinsecticidal activity of Murraya koenigii miraculin-like protein against Helicoverpa armigera and Spodoptera litura.

Gahloth D, Shukla U, Birah A, Gupta GP, Kumar PA, Dhaliwal HS, Sharma AK.

Arch Insect Biochem Physiol. 2011 Nov;78(3):132-44. doi: 10.1002/arch.20448. Epub 2011 Sep 21.

PMID:
21948662
29.

Nonclinical safety assessment of a synthetic peptide thrombopoietin agonist: effects on platelets, bone homeostasis, and immunogenicity and the implications for clinical safety monitoring of adverse bone effects.

Knight E, Eichenbaum G, Hillsamer V, Greway T, Tonelli A, Han-Hsu H, Zakszewski C, Yurkow E, Shukla U, End D, Louden C.

Int J Toxicol. 2011 Aug;30(4):385-404. doi: 10.1177/1091581811404708.

PMID:
21832269
30.

A comparative study of the effect of clonidine and tramadol on post-spinal anaesthesia shivering.

Shukla U, Malhotra K, Prabhakar T.

Indian J Anaesth. 2011 May;55(3):242-6. doi: 10.4103/0019-5049.82666.

31.

Postoperative analgesia in children when using clonidine or fentanyl with ropivacaine given caudally.

Shukla U, Prabhakar T, Malhotra K.

J Anaesthesiol Clin Pharmacol. 2011 Apr;27(2):205-10. doi: 10.4103/0970-9185.81842.

32.

Predictors of acute kidney injury post-cardiopulmonary bypass in children.

Sethi SK, Goyal D, Yadav DK, Shukla U, Kajala PL, Gupta VK, Grover V, Kapoor P, Juneja A.

Clin Exp Nephrol. 2011 Aug;15(4):529-34. doi: 10.1007/s10157-011-0440-2. Epub 2011 Apr 12.

PMID:
21479987
33.

Coffin-Siris syndrome with Mayer-Rokitansky-Küster-Hauser syndrome: a case report.

Goyal D, Yadav DK, Shukla U, Sethi SK.

J Med Case Rep. 2010 Nov 8;4:354. doi: 10.1186/1752-1947-4-354.

34.

Delayed pulmonary oedema following attempted suicidal hanging-a case report.

Kumar M, Mandhyan R, Shukla U, Kumar A, Rautela RS.

Indian J Anaesth. 2009 Jun;53(3):355-7.

35.

Hydrogeochemistry for the assessment of groundwater quality in Varanasi: a fast-urbanizing center in Uttar Pradesh, India.

Janardhana Raju N, Shukla UK, Ram P.

Environ Monit Assess. 2011 Feb;173(1-4):279-300. doi: 10.1007/s10661-010-1387-6. Epub 2010 Mar 11.

PMID:
20221794
36.

Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif.

Lu T, Markotan T, Ballentine SK, Giardino EC, Spurlino J, Crysler CS, Brown K, Maryanoff BE, Tomczuk BE, Damiano BP, Shukla U, End D, Andrade-Gordon P, Bone RF, Player MR.

J Med Chem. 2010 Feb 25;53(4):1843-56. doi: 10.1021/jm901802n. Erratum in: J Med Chem. 2010 Apr 22;53(8):3422. Crysler, Carl S [added].

PMID:
20102150
37.

Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT.

Shukla U, Hatani T, Nakashima K, Ogi K, Sada K.

J Biol Chem. 2009 Dec 4;284(49):33719-28. doi: 10.1074/jbc.M109.049999. Epub 2009 Oct 15.

38.

Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist.

Coltamai L, Bucher M, Maillard MP, Shukla U, Bohidar N, Haskell L, Bertelsen K, Fedgchin M, Vogt B, Burnier M.

Clin Pharmacol Ther. 2009 Feb;85(2):145-8. doi: 10.1038/clpt.2008.217. Epub 2008 Nov 5. No abstract available.

PMID:
18987622
39.
40.

Pharmacodynamic markers in the early clinical assessment of otamixaban, a direct factor Xa inhibitor.

Paccaly A, Ozoux ML, Chu V, Simcox K, Marks V, Freyburger G, Sibille M, Shukla U.

Thromb Haemost. 2005 Dec;94(6):1156-63.

PMID:
16411387
41.

Pharmacokinetic/pharmacodynamic relationships for otamixaban, a direct factor Xa inhibitor, in healthy subjects.

Paccaly A, Frick A, Ozoux ML, Chu V, Rosenburg R, Hinder M, Shukla U, Jensen BK.

J Clin Pharmacol. 2006 Jan;46(1):45-51.

PMID:
16397283
42.

Pharmacokinetics of otamixaban, a direct factor Xa inhibitor, in healthy male subjects: pharmacokinetic model development for phase 2/3 simulation of exposure.

Paccaly A, Frick A, Rohatagi S, Liu J, Shukla U, Rosenburg R, Hinder M, Jensen BK.

J Clin Pharmacol. 2006 Jan;46(1):37-44.

PMID:
16397282
43.

Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, with tirofiban in healthy volunteers.

Hinder M, Paccaly A, Frick A, Shukla U, Simcox K, Miller B, Gebauer A.

Thromb Haemost. 2005 Apr;93(4):794-5. No abstract available.

PMID:
15841331
44.

A designed protein interface that blocks fibril formation.

Shukla UJ, Marino H, Huang PS, Mayo SL, Love JJ.

J Am Chem Soc. 2004 Nov 3;126(43):13914-5.

PMID:
15506739
45.

Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.

Shukla UA, Chi EM, Lehr KH.

Ann Pharmacother. 2004 Jan;38(1):30-5.

PMID:
14742789
46.
47.

Biotransformation of insulin glargine after subcutaneous injection in healthy subjects.

Kuerzel GU, Shukla U, Scholtz HE, Pretorius SG, Wessels DH, Venter C, Potgieter MA, Lang AM, Koose T, Bernhardt E.

Curr Med Res Opin. 2003;19(1):34-40.

PMID:
12661778
48.

The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers.

Sanderink GJ, Le Liboux A, Jariwala N, Harding N, Ozoux ML, Shukla U, Montay G, Boutouyrie B, Miro A.

Clin Pharmacol Ther. 2002 Sep;72(3):308-18.

PMID:
12235452
49.

Efficacy of alpha, beta - Arteether in children with cerebral malaria in forested tribal belt.

Shukla UK, Damle RK, Shukla MM, Singh N.

Indian Pediatr. 2002 Jun;39(6):565-8. No abstract available.

PMID:
12084951
50.

One site fits both: a model for the ternary complex of folate + NADPH in R67 dihydrofolate reductase, a D2 symmetric enzyme.

Howell EE, Shukla U, Hicks SN, Smiley RD, Kuhn LA, Zavodszky MI.

J Comput Aided Mol Des. 2001 Nov;15(11):1035-52.

PMID:
11989624

Supplemental Content

Loading ...
Support Center